This is an exciting launch from our fellow Danaher Corporation operating company, Integrated DNA Technologies. IDT is continuously innovating on its cancer research solutions to fulfill its mission of accelerating the pace of genomics. #speedoflife
💥You asked, we answered!💥 We’re expanding our portfolio of comprehensive genomic profiling (#CGP) solutions by launching a homologous recombination deficiency (#HRD) assessment. Available as a standalone assay, spiked-in as a supplementary module, or integrated in an Archer #NGS panel, the new #HRDmodule complements existing Archer microsatellite (#MSI) and tumor mutational burden (#TMB) modules to create a flexible, customizable CGP solution for labs looking to optimize sequencing resources. Read more here: https://idtb.io/6jn6cg